Glycomimetics Stock Price Prediction

GLYC Stock  USD 0.32  0.03  10.34%   
The RSI of GlycoMimetics' the stock price is about 65. This usually indicates that the stock is rather overbought by investors at the present time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling GlycoMimetics, making its price go up or down.

Oversold Vs Overbought

65

 
Oversold
 
Overbought
The successful prediction of GlycoMimetics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with GlycoMimetics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting GlycoMimetics' stock price prediction:
EPS Estimate Next Quarter
(0.07)
Wall Street Target Price
1
EPS Estimate Current Quarter
(0.11)
Quarterly Revenue Growth
(1.00)
Using GlycoMimetics hype-based prediction, you can estimate the value of GlycoMimetics from the perspective of GlycoMimetics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in GlycoMimetics to buy its stock at a price that has no basis in reality. In that case, they are not buying GlycoMimetics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

GlycoMimetics after-hype prediction price

    
  USD 0.27  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out GlycoMimetics Basic Forecasting Models to cross-verify your projections.
For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlycoMimetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.081.5825.74
Details
1 Analysts
Consensus
LowTargetHigh
5.015.506.11
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

GlycoMimetics After-Hype Price Prediction Density Analysis

As far as predicting the price of GlycoMimetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in GlycoMimetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of GlycoMimetics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

GlycoMimetics Estimiated After-Hype Price Volatility

In the context of predicting GlycoMimetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on GlycoMimetics' historical news coverage. GlycoMimetics' after-hype downside and upside margins for the prediction period are 0.01 and 24.43, respectively. We have considered GlycoMimetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.32
0.27
After-hype Price
24.43
Upside
GlycoMimetics is out of control at this time. Analysis and calculation of next after-hype price of GlycoMimetics is based on 3 months time horizon.

GlycoMimetics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as GlycoMimetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GlycoMimetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with GlycoMimetics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  2.42 
24.18
  0.02 
  0.23 
6 Events / Month
11 Events / Month
In about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.32
0.27
6.90 
241,800  
Notes

GlycoMimetics Hype Timeline

GlycoMimetics is currently traded for 0.32. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -0.23. GlycoMimetics is anticipated to decline in value after the next headline, with the price expected to drop to 0.27. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -6.9%, whereas the daily expected return is currently at 2.42%. The volatility of related hype on GlycoMimetics is about 25452.63%, with the expected price after the next announcement by competition of 0.09. About 48.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.8. Some equities with similar Price to Book (P/B) outperform the market in the long run. GlycoMimetics recorded a loss per share of 0.62. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 6 days.
Check out GlycoMimetics Basic Forecasting Models to cross-verify your projections.
For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.

GlycoMimetics Related Hype Analysis

Having access to credible news sources related to GlycoMimetics' direct competition is more important than ever and may enhance your ability to predict GlycoMimetics' future price movements. Getting to know how GlycoMimetics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how GlycoMimetics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MLYSMineralys Therapeutics, Common 0.14 8 per month 3.42  0.02  6.27 (5.79) 20.98 
FHTXFoghorn Therapeutics(0.47)10 per month 4.44 (0) 8.50 (6.81) 34.64 
IVAInventiva Sa(0.08)3 per month 4.09  0.03  7.26 (6.92) 49.76 
DYNDyne Therapeutics 1.29 11 per month 0.00 (0.12) 5.70 (5.63) 32.93 
LIFEATyr Pharma 0.03 1 per month 2.62  0.07  6.45 (5.29) 28.98 
TRVITrevi Therapeutics(0.17)10 per month 3.66 (0.02) 6.59 (6.01) 17.04 
CUECue Biopharma 0.30 8 per month 5.85  0.08  20.27 (11.51) 67.78 
ANTXAN2 Therapeutics 0.01 9 per month 1.86  0.08  3.73 (3.42) 28.03 
BCABBioatla(0.13)10 per month 0.00 (0.03) 12.86 (7.59) 31.41 
ASMBAssembly Biosciences(0.32)5 per month 4.40 (0.01) 8.49 (5.34) 24.80 
SPROSpero Therapeutics 0.01 9 per month 0.00 (0.15) 3.79 (4.58) 14.92 
ACHLAchilles Therapeutics PLC(0.03)4 per month 1.55  0.11  3.06 (2.88) 38.16 
TILInstil Bio(1.77)9 per month 6.84  0.12  20.63 (10.89) 105.83 
NLTXNeoleukin Therapeutics(0.14)1 per month 0.00 (0.08) 4.05 (3.53) 27.84 

GlycoMimetics Additional Predictive Modules

Most predictive techniques to examine GlycoMimetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GlycoMimetics using various technical indicators. When you analyze GlycoMimetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About GlycoMimetics Predictive Indicators

The successful prediction of GlycoMimetics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as GlycoMimetics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of GlycoMimetics based on analysis of GlycoMimetics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to GlycoMimetics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to GlycoMimetics's related companies.
 2021 2023 2024 (projected)
Days Sales Outstanding0.426.4K6.7K
PTB Ratio0.913.891.98

Story Coverage note for GlycoMimetics

The number of cover stories for GlycoMimetics depends on current market conditions and GlycoMimetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that GlycoMimetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about GlycoMimetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

GlycoMimetics Short Properties

GlycoMimetics' future price predictability will typically decrease when GlycoMimetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of GlycoMimetics often depends not only on the future outlook of the potential GlycoMimetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GlycoMimetics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding63.3 M
Cash And Short Term Investments41.8 M

Complementary Tools for GlycoMimetics Stock analysis

When running GlycoMimetics' price analysis, check to measure GlycoMimetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlycoMimetics is operating at the current time. Most of GlycoMimetics' value examination focuses on studying past and present price action to predict the probability of GlycoMimetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlycoMimetics' price. Additionally, you may evaluate how the addition of GlycoMimetics to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Commodity Directory
Find actively traded commodities issued by global exchanges